Tamsulosin hydrochloride sustained-release pellet and preparation method thereof
A technology of tamsulosin hydrochloride and sustained-release pellets, which can be used in microcapsules, pharmaceutical formulations, urinary system diseases, etc., and can solve the problems of packaging, transportation, and storage inconvenience, low drug release stability, and large gastrointestinal irritation. problems, to achieve the effect of improving bioavailability, small individual differences, and easy absorption
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0031] A tamsulosin hydrochloride sustained-release pellet, comprising drug-containing pellets and a coating layer, characterized in that: the coating layer wraps the drug-containing pellets, and the drug-containing pellets include: 0.2 mg tamsulol hydrochloride New, 70mg blank ball core, 150-250mg filler, 25-125mg lubricant, 5-50mg binder, the coating layer includes: 35-175mg Eudragit NE30D, 5-52mg talcum powder.
[0032] The optimal mass ratio of raw materials in the drug-containing pellets is: 0.2 mg tamsulosin hydrochloride, 70 mg blank core, 230 mg filler, 55 mg lubricant, and 10 mg binder.
[0033] The optimal mass ratio of raw materials in the coating layer is: 95mg Eudragit NE30D, 21mg talcum powder.
[0034] The filler is microcrystalline cellulose.
[0035] Described lubricant is talcum powder.
[0036] The binder is hypromellose.
[0037] The coating layer also includes traces of sodium lauryl sulfate or polyethylene glycol.
Embodiment 2
[0039] A preparation method of tamsulosin hydrochloride sustained-release pellets, comprising the following steps:
[0040] Step 1: material preparation: according to the above mass ratio, tamsulosin hydrochloride is pulverized with a pulverizer, and passed through a 100-mesh sieve;
[0041] Step 2: Mixing: Take tamsulosin hydrochloride and microcrystalline cellulose according to the above mass ratio and mix them in a three-dimensional mixer for 30 minutes to make a fine powder of the drug, and take it out for later use;
[0042] Step 3: Preparation of adhesive: Weigh an appropriate amount of hypromellose according to the above mass ratio, add an appropriate amount of hot water to prepare an adhesive with a concentration of 2%, and set aside;
[0043] Step 4: Pill making: put the mixed drug fine powder into the feeding tank of the centrifugal pellet machine, put the adhesive into the liquid supply tank, put the blank pellet core into the pot, turn on the machine, adjust the pa...
Embodiment 3
[0049] Indications: It is mainly used for symptoms such as urination disorders caused by benign prostatic hyperplasia, such as frequent urination, nocturia, and dysuria. Since this product achieves the therapeutic purpose by improving the smooth muscle function of the urethra, bladder neck and prostate, rather than shrinking hypertrophic glands, it is suitable for mild and moderate patients and those who have not caused severe voiding disorders, such as severe urinary retention. This product should not be taken alone.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com